|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Top Lists |
Insider Trading Graph View |
Insider Watch |
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise" - Peter Lynch ==>> What is insider trading>> |

| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded | Average Price | Total Amount |
Shares Ownership |
Filing |
| 2007-03-22 Sale |
2007-03-23 4:15 pm | HALOZYME THERAPEUTICS INC | HTI | Yocum Richard C (VP Clinical Development) | 29,858 | $8.489 | $253,456 | 65,975 (Direct) | View |
| Transaction & Date |
Reported Date |
Company | Symbol | Insider Relationship | Shares Traded | Average Price |
Total Amount |
Shares Ownership |
Filing |
| 2007-03-21 Exercise |
2007-03-23 4:15 pm | HALOZYME THERAPEUTICS INC | HTI | Yocum Richard C (VP Clinical Development) | 95,833 | $1.87 | $179,208 | 95,833 (Direct) |
View |
| Transaction & Date |
Reported Date | Exercisable Expiration | Company | Symbol | Insider Relationship |
Shares Traded |
Conversion Price | Shares Ownership |
Filing |
| 2008-02-06 Option Award |
2008-02-08 5:50 pm | 2009-02-06 2018-02-06 |
HALOZYME THERAPEUTICS INC | HALO | Yocum Richard C (VP-Clinical Development) | 28,800 | $5.6 | 150,943 (Direct) | View |
| 2007-03-21 Exercise | 2007-03-23 4:15 pm |
2005-05-12 2015-05-12 | HALOZYME THERAPEUTICS INC | HTI | Yocum Richard C (VP Clinical Development) | 29,858 | $1.87 | 188,118 (Direct) | View |
| 2007-03-21 Exercise | 2007-03-23 4:15 pm | 2005-05-12 2015-05-12 | HALOZYME THERAPEUTICS INC | HTI | Yocum Richard C (VP Clinical Development) | 65,975 | $1.87 | 122,143 (Direct) | View |
| 2007-02-05 Option Award | 2007-02-07 4:34 pm | 2008-02-05 2017-02-05 |
HALOZYME THERAPEUTICS INC | HTI | Yocum Richard C (VP Clinical Development) | 17,976 | $7.51 | 217,976 (Direct) |
View |
| 2005-05-12 Option Award | 2005-05-12 4:31 pm | 2005-05-12 2015-05-12 | HALOZYME THERAPEUTICS INC | HTI | Yocum Richard C (VP Clinical Development) | 200,000 | $1.87 | 200,000 (Direct) |
View |
|
© 2005-2008 SecForm4.Com All rights reserved. Archives: 2008 2007 2006 2005 2004 2003 Tue, 02 Dec 2008 23:00:56 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |